Short description
Imvaq Therapeutics is an innovative cancer immunotherapy company.
Description
Imvaq is a biotechnology firm developing novel immuno-oncologics to treat metastatic cancer. It focuses on developing therapeutic products that work in tandem with a patient's immune system to eradicate cancer locally and globally.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Sammamish, Washington, United States, North America
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Blurry Noaccess
Sign in for full access
Founders
Jedd Wolchok, John Choi, Liang Deng, Stewart Schuman, Wei Yan